Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Selling natural fruit drinks with no added sugar in 15+ countries and to companies such as Holland & Barrett, WHSmith, Brakes and Compass Group, Berrywhite have sold 500k+ units of healthier soft drinks to UK schools and hospitals. Est. 2012, the company has received 16 awards for product quality.
days to go:
Expired
investment:
£138,320
Cheese Posties are a subscription based service, providing all needed ingredients in perfectly proportioned packs to create gourmet cheese toasties at home. They currently have over 30 different flavour combinations and all come with a collectable trumps card and a toaster-friendly cooking bag.
days to go:
Expired
investment:
£20,322
Notes is a well-established coffee shop and wine bar concept with nine locations in central London. They pride themselves in being able to source and roast at their own roastery in Canning Town which provides over 1.4m cups of coffee a year. By serving high volumes of their single-origin speciality coffee, Notes have doubled their revenue to almost £5m by just opening shops in four locations since 2015.
days to go:
Expired
investment:
£1,194,330
Launched in 2017, Algarve Rock is on a mission to put Portuguese craft beer on the map with flavoursome beers that embody local ingredients. The global craft beer market is expected to reach nearly $187 billion by 2025. It has carved a niche for itself in only 18 months of its inception. The 3,000 litre Brew House associated fermentation vessels and auto bottling line allow them to produce 36,000 litres per month, readily expandable to 80,000 litres to meet growing demand. Algarve Rock was the winner of the Best Stout - Trujillo Festival 2018, Spain and is the house brewer for prestigious institutions like Quinta do Lago group and Casa do Frango restaurants in London. With the investment, the company will use 40% to open Algarve Rock-themed Brewbars and Brew kiosks, 10% in increasing exports especially to the UK and USA, 10% in strengthening brand identity, 15% in recruitment procedures, and 25% in increasing brewing capacity to cater to new markets.
days to go:
Expired
investment:
£281,607
